Key Highlights

● The trust held $287,367,170 at 30 June 2026, including about $3.5 million of interest.

● The redemption value was $10.12 per public share at 30 June 2026.

● The company has until 20 February 2028 to complete a business combination.

● Management concluded there is substantial doubt about continuing as a going concern.

Averin Capital Acquisition Corp. (NASDAQ:ACAA) is a Cayman Islands blank-check company, also called a special purpose acquisition company, that says it intends to target businesses at the intersection of technology and health. Its Class A ordinary shares trade on the Nasdaq Global Market as ACAA. Holders of the company's units were able to trade the shares and warrants separately from 10 April 2026, as announced on 8 April 2026; unseparated units continue under a different symbol. The warrants trade as ACAAW.

The trust and the redemption price

The latest filing is the quarterly report for the period ended 30 June 2026, with share counts given as of 5 August 2026. At that date there were 28,586,008 Class A shares and 7,096,502 Class B shares outstanding. The over-allotment was partly exercised in March 2026, which is why the share count exceeds the original 25,000,000 units. The sponsor, Averin Capital Acquisition Sponsor LLC, owns about 20.4% of the ordinary shares. The filing also lists 4,731,001 public warrants and 33,333 private placement warrants, exercisable for 4,764,334 Class A shares in total, which is a source of potential dilution if they are exercised.

The trust account held $287,367,170 at 30 June 2026, including about $3.5 million of interest income. The balance sheet shows a redemption value of $10.12 per public share at that date, compared with the $10.00 per unit placed in trust at the February 2026 offering. Public shareholders may redeem their shares when a business combination closes, or if the company fails to complete one in time. Redemptions are capped at 15% of shares without the company's consent, and the sponsor and insiders have waived redemption rights over their founder and private placement shares.

Deadline and financial position

The company has until 20 February 2028 to complete a business combination, or until 20 May 2028 if a definitive agreement has been signed by 20 February 2028. As of 30 June 2026 it had no target or business combination agreement. Any deal would require terms to be negotiated, disclosed and normally put to a shareholder vote, none of which has occurred according to the filing.

Net income was $3,188,056 for the six months and $2,355,556 for the quarter. The filing reports cash of $339,276 and working capital of $338,659 outside the trust, and the company pays the sponsor $10,000 a month for administrative services. Management concluded that there is substantial doubt about the company's ability to continue as a going concern, with its plan resting on completing a combination before the mandatory liquidation date.

Redemption Floor Versus Deal Risk Before the 2028 Deadlines

The $10.12 redemption value is the main anchor for a holder, because it is the cash entitlement if the shares are redeemed. The reported income reflects trust interest and the structure, not any operating progress. Interest accrues only while funds sit in trust and does not guarantee future value.

The trade-off is time and uncertainty. A holder who keeps shares through a deal is exposed to the target's quality and to terms not yet known, whereas the redemption right provides a floor only at the time redemption is available, and its value depends on trust balances at that date.

The next disclosed milestones are the February 2028 deadline, the possible May 2028 extension, and future periodic filings.